0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Adriana Feder, MD; Michael K. Parides, PhD; James W. Murrough, MD; et al.
JAMA Psychiatry. 2014;71(6):681-688. doi:10.1001/jamapsychiatry.2014.62.
Includes: CME, Supplemental Content

Viewpoint | 
Ian R. H. Rockett, PhD, MPH; Nestor D. Kapusta, MD; Jeffrey H. Coben, MD
JAMA Psychiatry. 2014;71(3):231-232. doi:10.1001/jamapsychiatry.2013.3738.

Original Investigation | 
Hsien-Yuan Lane, MD, PhD; Ching-Hua Lin, MD, PhD; Michael F. Green, PhD; et al.
JAMA Psychiatry. 2013;70(12):1267-1275. doi:10.1001/jamapsychiatry.2013.2159.

Original Article |  FREE
Eugene C. Somoza, MD, PhD; Douglas Winship, BS; Charles W. Gorodetzky, MD, PhD; et al.
JAMA Psychiatry. 2013;70(6):630-637. doi:10.1001/jamapsychiatry.2013.872.
Includes: Supplemental Content

Original Article |  FREE
Mark Olfson, MD, MPH; Carlos Blanco, MD, PhD; Shang-Min Liu, MS; et al.
Arch Gen Psychiatry. 2012;69(12):1247-1256. doi:10.1001/archgenpsychiatry.2012.647.
Includes: Supplemental Content

Original Article |  FREE
Steven E. Arnold, MD; Li-Ying Han, MS; Paul J. Moberg, PhD; et al.
Arch Gen Psychiatry. 2001;58(9):829-835. doi:10.1001/archpsyc.58.9.829.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Trends in Boxed Warnings and Withdrawals for Novel Therapeutic Drugs, 1996 Through 2012
Christine M. Cheng, PharmD; Jaekyu Shin, PharmD, MS; B. Joseph Guglielmo, PharmD
JAMA
Review  | 
Treatment of Hepatitis C:  A Systematic Review
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA
Original Investigation  | 
Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.